Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

The Lancet. Respiratory medicine, 2023 Sep. Brown SM, Barkauskas CE, Grund B and 85 others.

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Indexed under

MeSH terms assigned by the National Library of Medicine.

Other papers on VIP

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.